[1]
Bragagni, M. et al. 2012. Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain Targeting. Journal of Pharmacy & Pharmaceutical Sciences. 15, 1 (Feb. 2012), 184–196. DOI:https://doi.org/10.18433/J3230M.